Latest filing published 07 May 2009 for SyntheMed, Inc., €2,413.
No signal scores available.
David G. P. Allan appears in our data through filings on SyntheMed, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 April 2009 to 31 December 2009, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 6 January 2010, the filings show a share grant worth €2,268 in SyntheMed, Inc. The median gap between a trade and its publication by SEC (Form 4) is 31 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration